Little info for those that are interested...

ARIAD To Webcast Conference Call On Fourth Quarter And Year-End 2009 Financial Results | Press Releases | Financial Articles & Investing News | TheStreet.com


ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia | Business Wire